Market Snapshot

BSE Sensex: 78041.59 -1.49%
BSE 500: 35082.25 -1.90%
BSE 200: 10905.86 -1.89%
BSE 100: 25006.81 -1.76%
BSE MidCap: 46226.5 -2.43%
BSE SmallCap: 55149.22 -2.11%
BSE BANKEX: 57752 -1.66%
BSE IT: 43608.13 -2.51%
Nifty 50: 23587.5 -1.52%
Nifty 500: 22319.4 -1.90%
Nifty 200: 13373.9 -1.94%
Nifty 100: 24448.85 -1.75%
Nifty Midcap 100: 56906.75 -2.82%
Nifty Small 100: 18714.3 -2.19%
Nifty IT: 43771.05 -2.63%
Nifty PSU Bank: 6575.7 -2.65%

News:

Can Fin Homes CFO Apurav Agarw...
Auro Pharma gets UK MHRA nod f...
Reliance Inds arm to acquire 4...
Mazagon Dock Shipbuilders deli...
Dalmia Bharats president Rajiv...

ERIS Lifesciences Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

Invest

20 Dec 2024 | 03:59 PM

1,378.25

-17.20 (-1.23%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Outperforms Index

58.49%

Return (1Y)

Beaten BSE Healthcare by 11.83%
More Volatile

1.82%

Standard Deviation (1Y)

Higher than BSE Healthcare by 0.96%
Not so consistent

6/12

Months

underperformed BSE Healthcare
AxisDirect View

No View

52 Week High-Low

1,593

810

News & Announcements

Board of Eris Lifesciences approves acquisition of 30% stake in Levim Lifetech
59 days ago

Board of Eris Lifesciences approves acquisition of 30% stake in Levim Lifetech

25 - Oct - 2024 12:00 AM | 59 days ago

The Board of Eris Lifesciences at its meeting held on 25 October 2024 has approved the execution of Binding Term Sheet with Levim Lifetech and its shareholders for the purpose of acquiring 30% stake in Levim Lifetech for an investment of Rs 54 crore at a pre-money equity valuation of Rs 126 crore. The acquisition is aimed at expansion of the company's biotechnology footprint across a wide range of products and technologies.
Powered by Capital Market - Live News
ERIS Lifesciences consolidated net profit declines 25.80% in the September 2024 quarter
59 days ago

ERIS Lifesciences consolidated net profit declines 25.80% in the September 2024 quarter

25 - Oct - 2024 12:00 AM | 59 days ago

Net profit of ERIS Lifesciences declined 25.80% to Rs 91.59 crore in the quarter ended September 2024 as against Rs 123.43 crore during the previous quarter ended September 2023. Sales rose 47.64% to Rs 738.95 crore in the quarter ended September 2024 as against Rs 500.52 crore during the previous quarter ended September 2023.
Particulars Quarter Ended
Sep. 2024 Sep. 2023 % Var.
Sales 738.95 500.52 48
OPM % 35.80 36.19 -
PBDT 209.59 168.33 25
PBT 129.11 126.24 2
NP 91.59 123.43 -26
Powered by Capital Market - Live News
ERIS Lifesciences announces board meeting date
62 days ago

ERIS Lifesciences announces board meeting date

22 - Oct - 2024 12:00 AM | 62 days ago

ERIS Lifesciences will hold a meeting of the Board of Directors of the Company on 25 October 2024.
Powered by Capital Market - Live News
ERIS Lifesciences to convene AGM
140 days ago

ERIS Lifesciences to convene AGM

05 - Aug - 2024 12:00 AM | 140 days ago

ERIS Lifesciences announced that the 18th Annual General Meeting (AGM) of the company will be held on 25 September 2024.
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

ERIS Lifesciences Ltd has given the 3rd best dividend yield 0.72 for 3 Year among stocks in Pharmaceuticals Sector
FII shareholding in ERIS Lifesciences Ltd has decreased by -45.07% since past 3 Months
MF shareholding in ERIS Lifesciences Ltd has increased by 17.28% since past 3 Months
FII shareholding in ERIS Lifesciences Ltd has decreased by -39.28% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Sep. 2024	Sep. 2023	% Var.
Sales	738.95	500.52	48
OPM %	35.80	36.19	-
PBDT	209.59	168.33	25
PBT	129.11	126.24	2
NP	91.59	123.43	-26

General Notifications

My Notifications

Research Notifications

ERIS Lifesciences Ltd Share Price – NSE / BSE Pharmaceuticals, Small Cap

1,378.25 -17.20 (-1.23%)

News & Announcements

Price vs Volume

Stock Trivia

ERIS Lifesciences Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

1,378.25

-17.20 (-1.23%)